RT Journal Article
SR Electronic
T1 Novel risk loci for COVID-19 hospitalization among admixed American populations
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.08.11.23293871
DO 10.1101/2023.08.11.23293871
A1 Diz-de Almeida, Silvia
A1 Cruz, Raquel
A1 Luchessi, Andre D.
A1 Lorenzo-Salazar, José M.
A1 de Heredia, Miguel López
A1 Quintela, Inés
A1 González-Montelongo, Rafaela
A1 Silbiger, Vivian N.
A1 Porras, Marta Sevilla
A1 Tenorio Castaño, Jair Antonio
A1 Nevado, Julian
A1 Aguado, Jose María
A1 Aguilar, Carlos
A1 Aguilera-Albesa, Sergio
A1 Almadana, Virginia
A1 Almoguera, Berta
A1 Alvarez, Nuria
A1 Andreu-Bernabeu, Álvaro
A1 Arana-Arri, Eunate
A1 Arango, Celso
A1 Arranz, María J.
A1 Artiga, Maria-Jesus
A1 Baptista-Rosas, Raúl C.
A1 Barreda- Sánchez, María
A1 Belhassen-Garcia, Moncef
A1 Bezerra, Joao F.
A1 Bezerra, Marcos A.C.
A1 Boix-Palop, Lucía
A1 Brion, María
A1 Brugada, Ramón
A1 Bustos, Matilde
A1 Calderón, Enrique J.
A1 Carbonell, Cristina
A1 Castano, Luis
A1 Castelao, Jose E.
A1 Conde-Vicente, Rosa
A1 Cordero-Lorenzana, M. Lourdes
A1 Cortes-Sanchez, Jose L.
A1 Corton, Marta
A1 Darnaude, M. Teresa
A1 De Martino-Rodríguez, Alba
A1 del Campo-Pérez, Victor
A1 de Bustamante, Aranzazu Diaz
A1 Domínguez-Garrido, Elena
A1 Eirós, Rocío
A1 Fariñas, María Carmen
A1 Fernandez-Nestosa, María J.
A1 Fernández-Robelo, Uxía
A1 Fernández-Rodríguez, Amanda
A1 Fernández-Villa, Tania
A1 Gago-Domínguez, Manuela
A1 Gil-Fournier, Belén
A1 Gómez-Arrue, Javier
A1 Álvarez, Beatriz González
A1 Bernaldo de Quirós, Fernan Gonzalez
A1 González-Neira, Anna
A1 González-Peñas, Javier
A1 Gutiérrez-Bautista, Juan F.
A1 Herrero, María José
A1 Herrero-Gonzalez, Antonio
A1 Jimenez-Sousa, María A.
A1 Lattig, María Claudia
A1 Borja, Anabel Liger
A1 Lopez-Rodriguez, Rosario
A1 Mancebo, Esther
A1 Martín-López, Caridad
A1 Martín, Vicente
A1 Martinez-Nieto, Oscar
A1 Martinez-Lopez, Iciar
A1 Martinez-Resendez, Michel F.
A1 Martinez-Perez, Ángel
A1 Mazzeu, Juliana F.
A1 Macías, Eleuterio Merayo
A1 Minguez, Pablo
A1 Cuerda, Victor Moreno
A1 Oliveira, Silviene F.
A1 Ortega-Paino, Eva
A1 Parellada, Mara
A1 Paz-Artal, Estela
A1 Santos, Ney P.C.
A1 Pérez-Matute, Patricia
A1 Perez, Patricia
A1 Pérez-Tomás, M. Elena
A1 Perucho, Teresa
A1 Pinsach-Abuin, Mel·lina
A1 Pita, Guillermo
A1 Pompa-Mera, Ericka N.
A1 Porras-Hurtado, Gloria L.
A1 Pujol, Aurora
A1 León, Soraya Ramiro
A1 Resino, Salvador
A1 Fernandes, Marianne R.
A1 Rodríguez-Ruiz, Emilio
A1 Rodriguez-Artalejo, Fernando
A1 Rodriguez-Garcia, José A.
A1 Ruiz-Cabello, Francisco
A1 Ruiz-Hornillos, Javier
A1 Ryan, Pablo
A1 Soria, José Manuel
A1 Souto, Juan Carlos
A1 Tamayo, Eduardo
A1 Tamayo-Velasco, Alvaro
A1 Taracido-Fernandez, Juan Carlos
A1 Teper, Alejandro
A1 Torres-Tobar, Lilian
A1 Urioste, Miguel
A1 Valencia-Ramos, Juan
A1 Yáñez, Zuleima
A1 Zarate, Ruth
A1 de Rojas, Itziar
A1 Ruiz, Agustín
A1 Sánchez, Pascual
A1 Real, Luis Miguel
A1 ,
A1 Guillen-Navarro, Encarna
A1 Ayuso, Carmen
A1 Parra, Esteban
A1 Riancho, José A.
A1 Rojas-Martinez, Augusto
A1 Flores, Carlos
A1 Lapunzina, Pablo
A1 Carracedo, Ángel
YR 2024
UL http://medrxiv.org/content/early/2024/07/17/2023.08.11.23293871.abstract
AB The genetic basis of severe COVID-19 has been thoroughly studied, and many genetic risk factors shared between populations have been identified. However, reduced sample sizes from non-European groups have limited the discovery of population-specific common risk loci. In this second study nested in the SCOURGE consortium, we conducted a GWAS for COVID-19 hospitalization in admixed Americans, comprising a total of 4,702 hospitalized cases recruited by SCOURGE and seven other participating studies in the COVID-19 Host Genetic Initiative. We identified four genome-wide significant associations, two of which constitute novel loci and were first discovered in Latin American populations (BAZ2B and DDIAS). A trans-ethnic meta-analysis revealed another novel cross-population risk locus in CREBBP. Finally, we assessed the performance of a cross-ancestry polygenic risk score in the SCOURGE admixed American cohort. This study constitutes the largest GWAS for COVID-19 hospitalization in admixed Latin Americans conducted to date. This allowed to reveal novel risk loci and emphasize the need of considering the diversity of populations in genomic research.Competing Interest StatementThe authors have declared no competing interest.Funding StatementInstituto de Salud Carlos III (COV20_00622 to A.C., COV20/00792 to M.B., COV20_00181 to C.A., COV20_1144 to M.A.J.S. and A.F.R., PI20/00876 to C.F.); European Union (ERDF) <<A way of making Europe>>. Fundacion Amancio Ortega, Banco de Santander (to A.C.), Estrella de Levante S.A. and Colabora Mujer Association (to E.G.-N.) and Obra Social La Caixa (to R.B.); Agencia Estatal de Investigacion (RTC-2017-6471-1 to C.F.), Cabildo Insular de Tenerife (CGIEU0000219140 <<Apuestas cientificas del ITER para colaborar en la lucha contra la COVID-19>> to C.F.) and Fundacion Canaria Instituto de Investigacion Sanitaria de Canarias (PIFIISC20/57 to C.F.). SD-DA was supported by a Xunta de Galicia predoctoral fellowship. Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics and Scientific Committees from the participating centres and by the Galician Ethics Committee Ref 2020/197 gave ethical approval for this work. Recruitment of patients from IMSS (in Mexico, City), was approved by of the National Comitte of Clinical Research, from Instituto Mexicano del Seguro Social, Mexico (protocol R-2020-785-082).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesSummary statistics from the SCOURGE Latin-American GWAS will be available at https://github.com/CIBERER/Scourge-COVID19